12:00 AM
 | 
May 13, 2013
 |  BC Week In Review  |  Clinical News  |  Regulatory

Ragweed Allergy Immunotherapy Tablet regulatory update

Merck said FDA accepted for review a BLA for Ragweed AIT in adults with ragweed-induced allergic rhinitis. The pharma submitted the BLA in March and said it expects a decision on the application in 1H14; the specific...

Read the full 162 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >